ESMO Conference Platform

ESMO Gynaecological Cancers Virtual Congress 2021

Final Programme PDF Advanced Search

11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00

Channel 1

15:05(1h 15m)1st line maintenance strategy options for advanced ovarian cancer by HRD profile
16:35(1h)AstraZeneca - Key questions on PARP inhibitors in ovarian cancer: Experts evaluate the latest evidence
11:30(1h)GSK – Molecular profiling in advanced ovarian cancer: What do we know?
17:50(1h 15m)How to deal with the different challenges in your professional career
13:35(1h 15m)Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
12:45(35m)Welcome to ESMO Gynae 2021 and Keynote address

Lounge

19:10(1h)How to choose and what to expect from a mentor?